Female and Male Phenotypes of Iron Deficiency in CHF. Additional analysis of the «The Prevalence of Iron Deficiency in Patients With Chronic Heart Failure in the Russian Federation (J-CHF-RF)» study

Aim    To evaluate the incidence of iron deficiency (ID) in men and women with chronic heart failure (CHF) and to compare clinical and functional indexes in patient with and without ID depending on the gender.
Material and methods    An additional analysis of the study “Prevalence of Iron Deficiency in Patients With Chronic Heart Failure in the Russian Federation (ID-CHF-RF)” was performed. The study included 498 (198 women, 300 men) patients with CHF, in whom, in addition to iron metabolism, the quality of life and exercise tolerance (ET) were studied. 97 % of patients were enrolled during their stay in a hospital. ID was defined in consistency with the European Society of Cardiology (ESC) Guidelines. Also, and additional analysis was performed according to ID criteria validated by the morphological picture of the bone marrow.
Results    ID was detected in 174 (87.9 %) women and 239 (79.8 %) men (p=0.028) according to the ESC criteria, and in 154 (77.8 %) women and 217 (72.3 %) men (p=0.208) according to the criteria validated by the morphological picture of the bone marrow. Men with ID were older and had more severe CHF. They more frequently had HF functional class (FC) III and IV (63.4 % vs. 43.3 % in men without ID); higher concentrations of N-terminal pro-brain natriuretic peptide (NT-proBNP) and lower ET. HF FC III increased the probability of ID presence 3.4 times (p=0.02) and the probability of HF FC IV 13.7 times (p=0.003). This clinical picture was characteristic of men when either method of determining ID was used. In women, ID was not associated with more severe CHF.
Conclusion    Based on the presented analysis, it is possible to characterize the male and female ID phenotypes. The male ID phenotype is associated with more severe CHF, low ET, and poor quality of life. In females of the study cohort, ID was not associated with either the severity of CHF or with ET.

1. Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D’Agostino RB, Kannel WB et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106(24):3068–72

2. Ceia F, Fonseca C, Mota T, Morais H, Matias F, de Sousa A et al. Preva lence of chronic heart failure in Southwestern Europe: the EPICA study. European Journal of Heart Failure. 2002;4(4):531–9. DOI: 10.1016/S1388-9842(02)00034-X

3. Kobalava Zh.D., Kokhan E.V., Kiyakbaev G.K., Shavarov A.A. Gender Specific Characteristics of Ventricular-Atrial Remodeling in Recurrent Atrial Fibrillation in Ischemic Heart Disease Patients With Arterial Hypertension. Kardiologiia. 2017;17(12):25–33. DOI: 10.18087/cardio.2017.12.10063

4. Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S et al. Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association. Circulation. 2018;137(12):e67–492. DOI: 10.1161/CIR.0000000000000558

5. Fliegner D, Schubert C, Penkalla A, Witt H, Kararigas G, Dworatzek E et al. Female sex and estrogen receptor-β attenuate cardiac remodeling and apoptosis in pressure overload. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2010;298(6):R1597–606. DOI: 10.1152/ajpregu.00825.2009

6. Lam CSP, Cheng S, Choong K, Larson MG, Murabito JM, Newton-Cheh C et al. Influence of Sex and Hormone Status on Circulating Natriuretic Peptides. Journal of the American College of Cardiology. 2011;58(6):618–26. DOI: 10.1016/j.jacc.2011.03.042

7. Glezer M.G. Gender and Age Characteristics of Mortality From Diseases of the Circulatory System of the Moscow region. Data 2016 year. Kardiologiia. 2019;59(1):49–56. DOI: 10.18087/cardio.2019.1.10215

8. Colbert JD, Martin B-J, Haykowsky MJ, Hauer TL, Austford LD, Arena RA et al. Cardiac rehabilitation referral, attendance and mortality in women. European Journal of Preventive Cardiology. 2015;22(8):979–86. DOI: 10.1177/2047487314545279

9. Lewis EF, Lamas GA, O’Meara E, Granger CB, Dunlap ME, McKelvie RS et al. Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM. European Journal of Heart Failure. 2007;9(1):83–91. DOI: 10.1016/j.ejheart.2006.10.012

10. Begrambekova Yu.L., Mareev V.Yu., Drobizhev M.Yu. Influence of psychoemotional disorders on the effectiveness of education and active outpatient control in heart failure patients. Russian Journal of Cardiolo gy. 2016;21(8):48–52. DOI: 10.15829/1560-4071-2016-8-48-52

11. Cleland JGF, Zhang J, Pellicori P, Dicken B, Dierckx R, Shoaib A et al. Prevalence and Outcomes of Anemia and Hematinic Deficiencies in Patients With Chronic Heart Failure. JAMA Cardiology. 2016;1(5):539. DOI: 10.1001/jamacardio.2016.1161

12. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation. 2003;107(2):223–5. DOI: 10.1161/01.CIR.0000052622.51963.FC

13. Fitzsimons S, Yeo TJ, Ling LH, Sim D, Leong KTG, Yeo PSD et al. Impact of change in iron status over time on clinical outcomes in heart failure according to ejection fraction phenotype. ESC Heart Failure. 2021;8(6):4572–83. DOI: 10.1002/ehf2.13617

14. Parikh A, Natarajan S, Lipsitz SR, Katz SD. Iron Deficiency in Community-Dwelling US Adults With Self-Reported Heart Failure in the National Health and Nutrition Examination Survey III: Prevalence and Associations With Anemia and Inflammation. Circulation: Heart Failure. 2011;4(5):599–606. DOI: 10.1161/CIRCHEARTFAILURE.111.960906

15. Rocha BML, Cunha GJL, Menezes Falcão LF. The Burden of Iron Deficiency in Heart Failure. Journal of the American College of Cardiology. 2018;71(7):782–93. DOI: 10.1016/j.jacc.2017.12.027

16. Mareev V.Yu., Begrambekova Yu.L., Mareev Yu.V., Kobalava Zh.D., Karapetyan L.V., Galochkin S.A. et al. Iron deficiency in Russia heart failure patients. Observational cross-sectional multicenter study. Kardiologiia. 2022;62(5):4–8. DOI: 10.18087/cardio.2022.5.n2083

17. Von Haehling S, Gremmler U, Krumm M, Mibach F, Schön N, Taggeselle J et al. Prevalence and clinical impact of iron deficiency and anaemia among outpatients with chronic heart failure: The PrEP Registry. Clinical Research in Cardiology. 2017;106(6):436–43. DOI: 10.1007/s00392-016-1073-y

18. Aleksandrova E.A., Khabibullina A.R. Health-related quality of life measurement using EQ-5D-3L questionnaire. Medical Journal of the Russian Federation. 2019;25(4):202–9. DOI: 10.18821/0869-2106-2019-25-4-202-209

19. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal. 2021;42(36):3599–726. DOI: 10.1093/eurheartj/ehab368

20. Grote Beverborg N, Klip IjT, Meijers WC, Voors AA, Vegter EL, van der Wal HH et al. Definition of Iron Deficiency Based on the Gold Standard of Bone Marrow Iron Staining in Heart Failure Patients. Circulation: Heart Failure. 2018;11(2):e004519. DOI: 10.1161/CIRCHEARTFAILURE.117.004519

21. Ho JE, Enserro D, Brouwers FP, Kizer JR, Shah SJ, Psaty BM et al. Pre- dicting Heart Failure With Preserved and Reduced Ejection Frac- tion: The International Collaboration on Heart Failure Subtypes. Circulation: Heart Failure. 2016;9(6):e003116. DOI: 10.1161/CIRCHEARTFAILURE.115.003116

22. Stolfo D, Uijl A, Vedin O, Strömberg A, Faxén UL, Rosano GMC et al. Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum. JACC: Heart Failure. 2019;7(6):505–15. DOI: 10.1016/j.jchf.2019.03.011

23. Polyakov D.S., Fomin I.V., Shkarin V.V., Gurvich E.V., Kraiem N. EPOCHA–D–CHF: gender differences in prognosis for acute decompensated heart failoure in real clinical practice (part 1). Women’s health problems. 2017;12(2):11–21.

24. Kaluzna-Oleksy M, Sawczak F, Kukfisz A, Szczechla M, Krysztofiak H, Wleklik M et al. Appetite and Nutritional Status as Potential Manage ment Targets in Patients with Heart Failure with Reduced Ejection Fraction—The Relationship between Echocardiographic and Biochemical Parameters and Appetite. Journal of Personalized Medicine. 2021;11(7):639. DOI: 10.3390/jpm11070639

25. Sandek A, Bauditz J, Swidsinski A, Buhner S, Weber-Eibel J, von Haehling S et al. Altered Intestinal Function in Patients With Chronic Heart Failure. Journal of the American College of Cardiology. 2007;50(16):1561–9. DOI: 10.1016/j.jacc.2007.07.016

26. Van Der Wal HH, Grote Beverborg N, Dickstein K, Anker SD, Lang CC, Ng LL et al. Iron deficiency in worsening heart failure is associated with reduced estimated protein intake, fluid retention, inflammation, and antiplatelet use. European Heart Journal. 2019;40(44):3616–25. DOI: 10.1093/eurheartj/ehz680

27. Valentova M, von Haehling S, Bauditz J, Doehner W, Ebner N, Bekfani T et al. Intestinal congestion and right ventricular dysfunction: a link with appetite loss, inflammation, and cachexia in chronic heart failure. European Heart Journal. 2016;37(21):1684–91. DOI: 10.1093/eurheartj/ehw008

28. Milman N, Taylor CL, Merkel J, Brannon PM. Iron status in pregnant women and women of reproductive age in Europe. The American Journal of Clinical Nutrition. 2017;106(Suppl 6):1655S-1662S. DOI: 10.3945/ajcn.117.156000

29. Badin Yu.V., Fomin I.V., Polyakov D.S. Dynamics of the prevalence of modifiable cardiovascular risk factors in the European part of the Russian Federation. South Russian Journal of Therapeutic Practice. 2021;2(2):16–25. DOI: 10.21886/2712-8156-2021-2-2-16-25

30. Martens P, Nijst P, Verbrugge FH, Smeets K, Dupont M, Mullens W. Impact of iron deficiency on exercise capacity and out-come in heart failure with reduced, mid-range and preserved ejection fraction. Acta Cardiologica. 2018;73(2):115–23. DOI: 10.1080/00015385.2017.1351239

31. Lundorff IJ, Sengeløv M, Jørgensen PG, Pedersen S, Modin D, Eske Bruun N et al. Echocardiographic Predictors of Mortality in Women With Heart Failure With Reduced Ejection Fraction. Circulation: Cardiovascular Imaging. 2018;11(11):e008031. DOI: 10.1161/CIRCIMAGING.118.008031

32. Beale AL, Nanayakkara S, Segan L, Mariani JA, Maeder MT, van Empel V et al. Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology. JACC: Heart Failure. 2019;7(3):239–49. DOI: 10.1016/j.jchf.2019.01.004

33. Pandey A, Cornwell WK, Willis B, Neeland IJ, Gao A, Leonard D et al. Body Mass Index and Cardiorespiratory Fitness in Mid-Life and Risk of Heart Failure Hospitalization in Older Age. JACC: Heart Failure. 2017;5(5):367–74. DOI: 10.1016/j.jchf.2016.12.021